carmen puliafito

We discuss the treatment results of high dose aflibercept in the eyes in the most severe quartile of diabetic macular edema with Dr. Roger Goldberg of Walnut Creek, California.

We discuss the baseline characteristics of eyes in the HD Aflibercept Phase III clinical trial and examine their ability for extended dosing with Dr. Eric Schneider of Tennessee Retina, Nashville, TN.

We discuss the unique results of the Annexon geographic atrophy Phase I clinical trial with Dr. Roger Goldberg of Bay Area Retina Associates, Walnut Creek, California

We discuss the use of blockade of VEGF C and D in the treatment of neovascular AMD with Dr. Dante Pieramici, California Retina Research Foundation, California Retina Consultants.

We discuss the use of the PDS in the treatment of diabetic retinopathy and diabetic macular edema with Professor Carl Regillo of the Wills Eye Hospital.

In our latest update, we discuss the relative drying effects of faricimab and aflibercept in the treatment of diabetic macular edema with Dr. Roger Goldberg.

We review the one year results of a clinical trial using high dose aflibercept (8mg) for the treatment of diabetic macular edema with Dr. David Boyer, Adjunct Clinical Professor of Ophthalmology, USC Roski Eye Institute

Thomas Albini, MD, Professor of Clinical Ophthalmology, University of Miami Miller School of Medicine, Bascom Palmer Eye Institute provides a comprehensive review of the etiology, diagnostic evaluation and treatment of retinal vasculitis.

We discuss the latest developments in diagnostic evaluation and treatment of eyes with central serous chorioretinopathy. with Roger Goldberg, MD, Bay Area Retina Associates, Walnut Creek, CA

Dr. Roger Goldberg from Bay Area Retina Associates, Walnut Creek, CA discusses the latest data regarding the use of faricimab in diabetic macular edema and neovascular AMD.

Dr. Dennis Marcus, Clinical Professor of Ophthalmology, Medical College of Georgia at Augusta University discusses the value of ultra wide field imaging in assessing diabetic retinopathy worsening over time.

Luzerne County native and three-time Pulitzer Prize-winning LA Times reporter Paul Pringle talks about investigative journalism and his new book, Bad City: Peril and Power in the City of Angels.

The true-crime events that lead to the investigation into USC School of Medicine Dean Dr. Carmen Puliafito are a shocking tale of drugs, sex, corruption, and several failed systems.

Paul discusses the reporting process, the behind-the-scenes story of why his editors would not publish his story about crime and corruption at the University of Southern California, the future of journalism, and a potential Hollywood deal for 'Bad City.'
You can subscribe to the News Engine Podcast wherever you get your favorite podcasts.

Listen and subscribe on Apple Podcasts

Listen and subscribe on Google Podcasts

Listen and subscribe on Spotify

You can subscribe to the News Engine Podcast wherever you get your favorite podcasts.

• Listen and subscribe on Apple Podcasts
• Listen and subscribe on Google Podcasts
• Listen and subscribe on Spotify

Contact News Engine: contactus@timesshamrock.com

If you know someone who you'd like to hear on the News Engine podcast or would like to join us we'd love to hear your guest suggestions.

Visit the News Engine homepage for extra photos and reader comments.

Thanks for listening!

We review lesion progression in the eighteen month data with Roger Goldberg, MD, MBA of Bay Area Retina Associates, Walnut Creek, California.

We discuss a new retinal sealant that may replace the need for tamponade with expansile gas or silicone oil with Dr. James Anthony Stefater.

We discuss the results of a Phase II clinical trail studying the efficacy of high dose aflibercept (8mg) for treating neovascular AMD with Dr. David Brown of Retina Consultants of Texas in Houston.

We discuss new developments in the diagnosis and therapy of choroidal melanoma with Dr. Paul Finger, Clinical Professor, NYU and Chair, Eye Cancer Foundation.

We discuss the two year results of a Phase I/II trial of a stem cell  implant for the treatment of geographic atrophy with Dr. Amir Kashani, Associate Professor, Wilmer Eye Institute.

We discuss the one year results of the DERBY and OAKs studies treating geographic atrophy with Dr. David Lally,  Assistant Professor University of Massachusetts and Tufts University.

We discuss the use of deep learning techniques in the detection and management of macular degeneration with Dr. Pearse Keane, Consultant Moorfields Eye Hospital, Professor of Artificial Medical Intelligence University College London.

In our latest update, We discuss the use of APX3330 a novel oral agent for the treatment of diabetic retinopathy with Dr. David Boyer, Retina Vitreous Associates, Adjunct Professor USC Roski Eye Institute.